Skip to main content
. 2021 Jan 14;195:57–71. doi: 10.1016/j.ymeth.2021.01.003

Table 7.

Main proteinase (3CLpro)Hits.

Dock ID Compound name Normal target Glide Energy DockScore LipophilicEvdW HBond Electro ExposPenal RotPenal
A XAV-939 Not known; Anti-cancer −71.17 −12.66 −5.74 −5.98 −1.46 0.37 0.15
B Crocin Arthritis −63.96 −11.56 −3.24 −6.68 −2 0.23 0.14
C Iopromide non-ionic X-ray contrast agent −77.95 −11.07 −5.34 −4.64 −1.63 0.39 0.15
D Troxerutin Chronic Venous Insufficiency −64.53 −10.69 −4.69 −4.29 −1.42 0 0.11
E Isoquercetin Anti-cancer −73.56 −10.31 −4.89 −4.42 −1.71 0.54 0.17
F Danoprevir Inhibitor of the HCV NS3/4A protease −66.83 −10.03 −4.73 −4.01 −1.44 0.04 0.11
G Cefoperazone Cephalosporin; antibacterial −79.52 −7.8 −3.14 −4.22 −1.67 0.7 0.19
H Nevirapine Non-nucleoside reverse transcriptase inhibitor (NNRTI) −63.17 −7.79 −3.31 −3.25 −1.09 0.11 0.14
I Pentostatin Adenosine deaminase; anti-cancer −81.01 −7.12 −3.78 −3.74 −2 2.09 0.19
J Cladribine Synthetic purine nucleoside that acts as an antineoplastic agent −78.93 −6.86 −5.19 −1.48 −1.09 0.85 0.19
K Bisindolylmaleimide IX PKC Inhibitor, Potential anti-cancer activity −56.2 −5.9 −5.1 −0.6 −0.6 0.1 0.3